Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mariko Asaoka
Observed names:
Asaoka, Mariko,
M Asaoka,
MARIKO ASAOKA
Institutions:
Roswell Park Comprehensive Cancer Center,
Tokyo Medical University,
Tokyo Medical University Hospital
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Tokyo Medical University,
Yokohama City University Medical Center,
Kyoto Prefectural University of Medicine,
Tokyo Medical University Hospital,
Yokohama Rosai Hospital,
Kanagawa Cancer Center,
Chigasaki Municipal Hospital
show all 8
ORCID:
0000-0002-4573-4572
Observed ORCID:
0000-0002-4573-4572
OpenAlex ID:
A5090406100
CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
2020
·
Masanori Oshi
, Mariko Asaoka
, et al.
·
International Journal of Molecular Sciences
·
236
PDF
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer
2020
·
Masanori Oshi
, Yoshihisa Tokumaru
, et al.
·
Scientific Reports
·
220
PDF
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients
2019
·
Kerry-Ann McDonald
, Tsutomu Kawaguchi
, et al.
·
Annals of Surgical Oncology
·
200
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
2020
·
Mariko Asaoka
, Shipra Gandhi
, et al.
·
Breast Cancer Basic and Clinical Research
·
191
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
2020
·
Masanori Oshi
, Mariko Asaoka
, et al.
·
Cancers
·
113
PDF
Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines
2020
·
Masako Muguruma
, Saeko Teraoka
, et al.
·
Biochemical and Biophysical Research Communications
·
105
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival
2019
·
Maiko Okano
, Masanori Oshi
, et al.
·
International Journal of Molecular Sciences
·
95
PDF
Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
2020
·
Hideo Takahashi
, Mariko Asaoka
, et al.
·
Scientific Reports
·
88
PDF
Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy
2019
·
Mariko Asaoka
, Kazutaka Narui
, et al.
·
European Journal of Surgical Oncology
·
79
Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
2022
·
Yara Abdou
, Medhavi Gupta
, et al.
·
Scientific Reports
·
74
PDF
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers
2020
·
Hideo Takahashi
, Masanori Oshi
, et al.
·
Annals of Surgical Oncology
·
63
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
2019
·
Takashi Takeshita
, Li Yan
, et al.
·
Scientific Reports
·
60
PDF
APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival
2019
·
Mariko Asaoka
, Takashi Ishikawa
, et al.
·
International Journal of Molecular Sciences
·
59
PDF
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
2020
·
Mariko Asaoka
, Santosh K. Patnaik
, et al.
·
Breast Cancer Research and Treatment
·
57
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
2020
·
Yoshihisa Tokumaru
, Mariko Asaoka
, et al.
·
International Journal of Molecular Sciences
·
54
PDF
High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer.
2019
·
Takashi Takeshita
, Mariko Asaoka
, et al.
·
Europe PMC (PubMed Central)
·
54
Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer
2023
·
Rongrong Wu
, Masanori Oshi
, et al.
·
Annals of Surgery
·
53
High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer
2022
·
Rongrong Wu
, Ankit Patel
, et al.
·
Breast Cancer Research and Treatment
·
45
PDF
Th2 cell infiltrations predict neoadjuvant chemotherapy response of estrogen receptor-positive breast cancer
2021
·
Lan Le
, Yoshihisa Tokumaru
, et al.
·
Gland Surgery
·
44
PDF
Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer.
2022
·
Rongrong Wu
, Irene Yu
, et al.
·
PubMed
·
43
NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
2022
·
Rongrong Wu
, Arya Roy
, et al.
·
Cancers
·
40
PDF
Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic
2023
·
Kayo Adachi
, Fuyo Kimura
, et al.
·
Clinical Breast Cancer
·
30
PDF
Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer
2020
·
Konstantinos Chouliaras
, Yoshihisa Tokumaru
, et al.
·
Surgery
·
29
Development of a novel BRCAness score that predicts response to PARP inhibitors
2022
·
Masanori Oshi
, Shipra Gandhi
, et al.
·
Biomarker Research
·
28
PDF
Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.
2022
·
Rongrong Wu
, Joy Sarkar
, et al.
·
PubMed
·
22
Show more works
View as search
Works count:
77
Citation count:
2,235
H-index:
24
I10-index:
31
Year
Topic
Type